Literature DB >> 19141132

Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center.

M Catherine Lee1, Kendra Rogers, Kent Griffith, Kathleen A Diehl, Tara M Breslin, Vincent M Cimmino, Alfred E Chang, Lisa A Newman, Michael S Sabel.   

Abstract

Bias in referral patterns and variations in multi-disciplinary management may impact breast conservation therapy (BCT) rates between hospitals. Retrospective studies of BCT rates are limited by their inability to differentiate indicated mastectomies versus those chosen by the patient. Our prospective breast cancer data base was queried for patients with invasive breast cancer who underwent surgical therapy at the University of Michigan over a 3-year period. Demographics, stage and histology were recorded along with the reason mastectomy was performed, categorized as "by need" (contraindication to BCT) or "by choice." Multivariate analysis was used to identify factors significantly associated with mastectomy by choice. BCT was associated with tumor size, histology and nodal status, but not older age, either by choice or by need. Of the 34% of patients initially felt to be poor candidates for BCT, it was absolutely contraindicated in 44%, while 56% were thought to have a tumor-to-breast size ratio too large for successful BCT. Of this latter group, 80% underwent neo-adjuvant chemotherapy in an attempt to downstage the primary tumor and perform BCT, which was successful in over half the patients. For the patients initially thought to be good candidates for BCT, only 15% chose to undergo mastectomy, while 5% eventually required mastectomy due to failed attempts to achieve negative margins. Overall, the BCT rate was 63%, however without the use of neo-adjuvant chemotherapy, the BCT rate would have been only 53%. At a tertiary referral center, BCT rates are driven more by contraindications than patient choice, and may be heavily skewed towards mastectomy due to referral patterns. In addition to tumor factors such as stage and histology, BCT rate can be dramatically impacted by neo-adjuvant chemotherapy or genetic counseling. Examining BCT rates alone as a measure of quality, therefore, is not an appropriate standard across institutions serving diverse populations.

Entities:  

Mesh:

Year:  2009        PMID: 19141132     DOI: 10.1111/j.1524-4741.2008.00668.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  24 in total

1.  Perceptions of care coordination in a population-based sample of diverse breast cancer patients.

Authors:  Sarah T Hawley; Nancy K Janz; Sarah E Lillie; Christopher R Friese; Jennifer J Griggs; John J Graff; Ann S Hamilton; Sarika Jain; Steven J Katz
Journal:  Patient Educ Couns       Date:  2010-11-12

2.  Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy.

Authors:  Kimito Yamada; Norio Kohno
Journal:  Gland Surg       Date:  2012-11

3.  High-throughput ultraviolet photoacoustic microscopy with multifocal excitation.

Authors:  Toru Imai; Junhui Shi; Terence T W Wong; Lei Li; Liren Zhu; Lihong V Wang
Journal:  J Biomed Opt       Date:  2018-03       Impact factor: 3.170

4.  Survival in stage I-III breast cancer patients by surgical treatment in a publicly funded health care system.

Authors:  S Fisher; H Gao; Y Yasui; K Dabbs; M Winget
Journal:  Ann Oncol       Date:  2015-02-23       Impact factor: 32.976

5.  Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.

Authors:  Sameer Damle; Christine B Teal; Joanne J Lenert; Elizabeth C Marshall; Qing Pan; Anita P McSwain
Journal:  Indian J Surg Oncol       Date:  2011-09-03

6.  Mastectomy versus breast-conservation therapy: an examination of how individual, clinicopathologic, and physician factors influence decision-making.

Authors:  J Gu; M Delisle; R Engler-Stringer; G Groot
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

7.  Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer.

Authors:  Harveshp D Mogal; Clancy Clark; Rebecca Dodson; Nora F Fino; Marissa Howard-McNatt
Journal:  Ann Surg Oncol       Date:  2016-09-21       Impact factor: 5.344

8.  Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.

Authors:  Kandace P McGuire; E Shelley Hwang; Alan Cantor; Mehra Golshan; Funda Meric-Bernstam; Janet K Horton; Rita Nanda; Keith D Amos; Andres Forero; Cliff A Hudis; Ingrid Meszoely; Jennifer F De Los Santos
Journal:  Ann Surg Oncol       Date:  2014-07-25       Impact factor: 5.344

9.  Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.

Authors:  Monica Morrow; Reshma Jagsi; Amy K Alderman; Jennifer J Griggs; Sarah T Hawley; Ann S Hamilton; John J Graff; Steven J Katz
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

10.  Advancing optical imaging for breast margin assessment: an analysis of excisional time, cautery, and patent blue dye on underlying sources of contrast.

Authors:  Torre M Bydlon; William T Barry; Stephanie A Kennedy; J Quincy Brown; Jennifer E Gallagher; Lee G Wilke; Joseph Geradts; Nimmi Ramanujam
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.